SPAP Implementation Questionnaire Sample Clauses

SPAP Implementation Questionnaire. ‌ The SPAP Implementation Questionnaire asks a series of questions of the data sharing partner that assists the BCRC and the partner in setting up the data sharing exchange process. These questions are intended to help you think through some of the issues which need to be addressed before you begin the data exchange and to assure that both the CMS and the SPAP partner are in agreement as to the operational process involved. SPAP partners must fill out, sign and return a copy of the Questionnaire to the CMS with their signed SPAP Data Sharing Agreement. The Questionnaire is also identified as Attachment C in the materials that new SPAP data sharing partners will acquire at the start of the implementation process. Chapter 4: Working with the Data ‌ 4.1 Updates to the SPAP Process‌ Some partners have seen an “ID” value in the Rx Current Disposition Code field (Field 19) for some records in their Response files. The “ID” Disposition Code is being caused by an identification error (an “ID” error) at the MBD, one of the systems feeding data to the BCRC. The records on Input Files from our partners are matched against MBD records. The ID Disposition Code problem arises in some cases because the BCRC tries to apply an incoming record to the MBD, but the MBD does not find any existing record for that particular beneficiary, even though the MBD has already told the BCRC that the record exists. Fortunately, while this is only happening in a very limited number of cases an SPAP might still get some records with the “ID” code, seeming to show that the MBD matching process does not identify the incoming record. However, response records transmitted to the SPAP do include whatever Medicare information the BCRC had already received from MBD and stored for that beneficiary in the BCRC’s own database. While the beneficiary’s data cannot yet be validated absent a confirmation of acceptance from MBD, CMS staff continues to work to resolve this data reporting problem. The MBD feed to the BCRC includes Co-Pay Level ID data for both the LIS and Deemed categories. Field 55 shows LIS Co-Pay Level ID information. Field 56 shows Deemed Co-Pay Level ID information. Partners should note that it is possible for an individual to have both LIS and Deemed Co-Pay Level ID information. For such individuals, the Deemed Co-Pay Level ID information in Field 56 takes priority over the LIS Co-Pay Level ID information in Field 55. Please review Fields 55 and 56 on the SPAP Response File layout, l...
AutoNDA by SimpleDocs

Related to SPAP Implementation Questionnaire

  • Interest Questionnaire - Form CIQ No response Do not upload this form unless you have a reportable conflict with TIPS. There is an Attribute entitled “Conflict of Interest Questionnaire Requirement” immediately followed by an Attribute entitled “Conflict of Interest Questionnaire Requirement – Form CIQ – Continued.” Properly respond to those Attributes and only upload this form if applicable/instructed. If upload is required based on your response to those Attributes, the Conflict of Interest Questionnaire – Form CIQ must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed, and uploaded at this location.

  • Drug-Free Workplace Certification As required by Executive Order No. 90-5 dated April 12, 1990, issued by the Governor of Indiana, the Company hereby covenants and agrees to make a good faith effort to provide and maintain a drug-free workplace at the Project Location. The Company will give written notice to the IEDC within ten (10) days after receiving actual notice that the Company, or an employee of the Company in the State of Indiana, has been convicted of a criminal drug violation occurring in the workplace. False certification or violation of this certification may result in sanctions including, but not limited to, suspension of payments under the Agreement, termination of the Agreement and/or debarment of contracting opportunities with the State for up to three (3) years. In addition to the provisions of the above paragraph, if the total amount set forth in the Agreement is in excess of $25,000.00, the Company agrees that it will provide a drug-free workplace by: A. Publishing and providing to all of its employees a statement notifying them that the unlawful manufacture, distribution, dispensing, possession or use of a controlled substance is prohibited in the Company’s workplace, and specifying the actions that will be taken against employees for violations of such prohibition;

  • Conflict of Interest Questionnaire Requirement Vendor agrees that it has looked up, read, and understood the current version of Texas Local Government Code Chapter 176 which generally requires disclosures of conflicts of interests by Vendor hereunder if Vendor:

  • Conflict of Interest Questionnaire - Form CIQ No response Do not upload this form unless you have a reportable conflict with TIPS. There is an Attribute entitled “Conflict of Interest Questionnaire Requirement” immediately followed by an Attribute entitled “Conflict of Interest Questionnaire Requirement – Form CIQ – Continued.” Properly respond to those Attributes and only upload this form if applicable/instructed. If upload is required based on your response to those Attributes, the Conflict of Interest Questionnaire – Form CIQ must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed, and uploaded at this location.

  • Implementation Report Within 150 days after the Effective Date, Halifax shall submit a written report to OIG summarizing the status of its implementation of the requirements of this CIA (Implementation Report). The Implementation Report shall, at a minimum, include: 1. the name, address, phone number, and position description of the Compliance Officer required by Section III.A.1, and a summary of other noncompliance job responsibilities the Compliance Officer may have; 2. the names and positions of the members of the Compliance Committee required by Section III.A.2; 3. the names of the Board members who are responsible for satisfying the Board of Commissioners compliance obligations described in Section III.A.3; 4. a copy of Halifax’s Code of Conduct required by Section III.B.1; 5. the number of individuals required to complete the Code of Conduct certification required by Section III.B.1, the percentage of individuals who have completed such certification, and an explanation of any exceptions (the documentation supporting this information shall be made available to OIG upon request); 6. a summary of all Policies and Procedures required by Section III.B (copies of the Policies and Procedures shall be made available to OIG upon request); 7. the following information regarding each type of training required by Section III.C: a. a description of such training, including a summary of the topics covered, the length of sessions, and a schedule of training sessions; b. the number of individuals required to be trained, percentage of individuals actually trained, and an explanation of any exceptions; and c. with respect to active medical staff members, the number and percentage who completed the training, the type of training and the date received, and a description of Halifax’s efforts to encourage medical staff members to complete the training. 8. a description of: (a) the Focus Arrangements Tracking System required by Section III.D.1.a; (b) the internal review and approval process required by Section III.D.1.e; and (c) the tracking and monitoring procedures and other Focus Arrangements Procedures required by Section III.D.1; 9. a description of the Disclosure Program required by Section III.F;

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!